Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...

Experts at City of Hope, Simon Nazarian and Nasim Eftekhari, discussed the transformative potential of AI in cancer care.

Researchers of a new JAMA study said that without further participation in accountable care organizations, including the ACO REACH model, the program is unlikely to meet its goal of reducing health ...

Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.

CVS Health released a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from ...

A panelist discusses how preserving beta-cell function in type 1 diabetes (T1D) requires a multifaceted approach combining timely diagnosis, immunomodulatory therapies, optimal glycemic control and ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In addition to its health impact on patients, PAH leads to high payer-paid medical and pharmacy costs, as well as high out-of-pocket costs. 6 According to a study of commercial insurance and Medicare ...

MHE: What are the latest insights into the underlying pathophysiology of pulmonary arterial hypertension (PAH)? Waxman: Lately, we’ve learned a great deal about the roles of vascular remodeling and ...